IFN-γ has strong antitumor functions that also rely on the induction of an anti-angiogenic cascade involving MIG and IP10 (CXCL9 and CXCL10) [79] and on a direct inhibitory effect on tumor cell growth in vivo [80]. This evidence concerns the gene CXCL9 and neoplasm.